[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]
[Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq XIANYANG, China, August 23, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announc]
[Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq XIANYANG, China, August 23, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announc]
[Biostar Pharmaceuticals Received Nasdaq Delisting Notification XIANYANG, China, July 25, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on July 19, 2018 it rece]
[Biostar Pharmaceuticals Received Nasdaq Delisting Notification XIANYANG, China, July 25, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on July 19, 2018 it rece]
[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): June 2, 2018 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, Pe]
[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): June 2, 2018 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, Pe]
[SHARE PURCHASE AGREEMENT 股份购买协议 ____ "Seller" _____ "Purchaser" This Share Purchase Agreement (the "Agreement") is made as of the 4th day of June, 2018 by and between Ronghua Wang, with the People's Republic of China (the "PRC") Passport No. 2018 6 4 E85615992 (" ") K04837814 (" ") 本股份购买协议（"本协议"）于 W]
[SHARE PURCHASE AGREEMENT 股份购买协议 ____ "Seller" _____ "Purchaser" This Share Purchase Agreement (the "Agreement") is made as of the 4th day of June, 2018 by and between Ronghua Wang, with the People's Republic of China (the "PRC") Passport No. 2018 6 4 E85615992 (" ") K04837814 (" ") 本股份购买协议（"本协议"）于 W]
